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SUMMARY
This dissertation describes a study into the dosimetric properties of several new forms
of spatially fractionated radiation therapy, commonly referred to as SFRT or GRID; small
beam electron GRID, radioisotope-based photon minibeam GRID, and megavoltage photon
minibeam GRID. For each methodology, a combination of Monte Carlo simulation (using
the Monte Carlo code MCNP6) and physical measurements (using EBT3 radiochromic
film) was used to characterize the dose rate and peak-to-valley dose ratio (PVDR) of each
of the proposed methods. This presented work shows the calculated and/or measured in-
phantom dose distributions from each of these new modalities. In all cases, beam definition
similar to or exceeding that of clinically used GRID therapy techniques was achieved, as
defined by the PVDR. In addition, the photon-based minibeam modalities were able to ef-
fectively produce beams below 5 mm in diameter, which could be expected to significantly
improve healthy tissue recovery. Also in this work, the limitations and challenges of each
of these techniques are discussed, namely the reduced dose rate that corresponds to the
small beam size. However, each method has some conditions under which it can effec-






While the treatment techniques have changed over the years, the goal of radiation therapy
has always been to administer dose in a way that maximizes the damage to a specific
volume of tissue while minimizing damage to any other tissue. In this way, cancerous (or
other diseased) tissue can be killed while minimizing the side effects that would result from
damage to healthy tissue. While a variety of treatment options exist to meet this constraint,
from brachytherapy (the temporary or permanent implantation of radioactive seeds into the
target tissue) to proton therapy (the use of high energy proton beams to deliver dose to
the target tissue), accelerator based photon therapy has been the most common treatment
modality.
In almost all modern photon treatments, healthy tissue dose is kept low by irradiating
the patient using beams from multiple different directions, or even by keeping the beam
on as the accelerator moves in an arc around the patient, while keeping the target tissue at
the center of rotation. While this can irradiate a relatively large volume of healthy tissue,
the dose to this tissue is kept low enough such that it does not cause any major damage.
However, this dose can increase the chance of secondary cancers, with some estimates
stating an almost twofold increase in cancer risk.[1]
However, it is also possible to reduce the side effects of radiation therapy by instead
concentrating the dose to healthy tissue into small beamlets through a technique known as
spatially fractionated radiation therapy (SFRT) or GRID therapy. In this style of therapy,
the healthy tissue in these regions of high dose are heavily damaged, but since the volume of
this damaged tissue is relatively small, the unirradiated healthy tissue around these regions
1
can quickly proliferate and repair the damage. In these styles of treatment, it is important
to both keep the high dose volume small [2] and to minimize the dose to the surrounding
tissue [3, 4] to maximize the clinical benefit and minimize the recovery time.
1.2 Objectives
This work will investigate several novel methods of administering SFRT and evaluate the
dose distributions resulting from the use of these methods for their suitability for clinical
application. All methods will have the primary goal of achieving a peak-to-valley dose ratio
(PVDR), that is, the ratio between the dose in beam (i.e. the peak dose) to out of beam(i.e.
the valley dose), that matches or exceeds the value for conventional GRID treatments. The
PVDR is a parameter used to evaluate the quality of the beam definition. The higher the
PVDR, the better the beam would perform in terms of normal tissue sparing during the
treatment. Each method also has a particular secondary goal in addition to this constraint.
The first modality, electron GRID, is intended to allow for the treatment of tumors between
the skin surface and radiosensitive organs (also known as organs at risk or OARs), as the
limited range of electrons in tissue leads to a significant reduction in the ”exit dose” past the
distal end of the tumor. The second, minibeam therapy with photon-emitting radioisotopes,
seeks to reduce the beam size to increase the potential radiobiological benefit . Finally,
linac-based MV photon minibeam therapy seeks to match the beam size achieved with the
radioisotopes while increasing the dose rate to allow for faster treatments.
The dose distributions from each of these methods will be calculated using the Monte
Carlo radiation transport code MCNP6[5]. In order to benchmark these simulations, com-
parable physical measurements were taken using EBT3 Gafchromic film (Ashland, Cov-
ington, KY).
2
1.3 Overview of GRID therapy
1.3.1 History of GRID therapy
Grid therapy is far from a new technique, it was first developed in 1909 by Alban Kohler
in Germany [6], and was independently introduced to the United States by F. Liberson [7]
in 1933. Initial designs used lead collimators with 1 cm diameter holes, with a spacing
to assure the grid gave a 50:50 open to shielded ratio. In both cases, it was developed to
address a critical problem with the orthovoltage treatments of the time: skin sparing. [8,
9] Because of the poor depth dose distribution of orthovoltage x-rays, where the maximum
dose was deposited at the surface and the dose to deeper tissues dropped off significantly, it
was impossible to administer a treatment dose to deep seated tumors without exceeding the
skin tolerance and causing highly detrimental biological effects in the healthy tissue. How-
ever, by irradiating in an array of beams instead of in a broad open field, healthy tissue was
protected from the radiation around each of the beamlets, allowing for centers of regrowth
that greatly improved the tissue’s ability to recover and therefore the skin tolerance. [10]
While the tumor did benefit somewhat from this spatial fractionation of the dose, animal
studies conducted by Urano et. al. found that grid therapy increased the tolerance of the
skin and other healthy tissue by a factor of 1.8, while the tumor tolerance only increased
by 1.23, leading to a gain of 1.5. [11] This difference in the tolerance of the skin and the
tumor to treatment is thought to be a result in the different tissue’s reaction to the bystander
effect, where unirradiated cells will experience similar damage and death as nearby irradi-
ated cells, though the exact biological reason for this difference in response is unknown.
[12]
1.3.2 Megavoltage GRID therapy
As accelerator technology advanced and higher energy beams became available, the use of
GRID became less necessary as megavoltage beams have a buildup region near the surface
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where they deposit relatively little dose. As the percent depth dose curves in Figure 1.1
show, higher energy beams deposit a much smaller percentage of their energy at shallow
depths compared to lower energy beams. Because of this, and the development of more
advanced treatment techniques such as IMRT and VMAT, GRID was no longer needed
for skin sparing for the majority of external beam treatments. However, for large and/or
radioresistant tumors, GRID therapy maintains its advantage over these new techniques,
such as for melanomas [13, 14], cervical cancers [15], head and neck cancers [16], lung
tumors [17], and others [18, 19, 20, 21]. Since the effective treatment of these tumors
require large doses in a single fraction, the use of GRID can minimize or avoid any severe
radiation induced side effects in the skin at the beam entrance. This is especially important
for bulky tumors because of the large field size needed to fully treat these kinds of tumors,
meaning that any late effects would encompass a considerable area of skin, and because
large tumors tend to be more radioresistant [22].
Figure 1.1: Percent depth dose curves from several photon beams of different energies. Br
J Radiol. 1978;(suppl 11); and the Appendix.
The specifics of these GRID treatments vary depending on what type of tumor is being
treated and which center is administering the treatment, but typically they are administered
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using a specially machined block (typically made of brass) [18], or using the multi-leaf
collimator (MLC) to create a checkerboard pattern [18, 23], slits [24] or even spheres (for
a 3D treatment) [25]. While the exact hole diameters and center-to-center spacings change
somewhat between centers, they tend to be around 1 cm and 2 cm respectively (measured
at isocenter). [18, 19, 23, 26] The peak dose administered to the tumor also ranges from
10 Gy [19] to 20 Gy [16, 19], but it is always administered in a single fraction. Both of
these methods have been found to give similar clinical results, though using the MLC gives
the advantage of not having to purchase additional equipment [26]. However, as the MLC
can physically only deliver a subset of the holes at a time, using a block decreases the
treatment time by a factor of 3-5 and can increase patient throughput [27]. This increase in
the amount of beam that needs to be delivered for the MLC treatments has also been shown
to decrease the PVDR in some cases due to leakage through the MLCs [18], though other
studies show similar PVDRs for both approaches [23].
Overall, GRID treatments have been shown to be effective, both via modeling and in
clinical use, for the treatment of a variety of different tumors. In all cases referenced here,
GRID was successfully used to administer a large dose in a single fraction with minimal
normal tissue effects.
1.4 Radiobiology
As mentioned above, the exact radiobiological mechanisms that underlay the effectiveness
of GRID therapy are not well understood [12], even though they can be modeled fairly ac-
curately [14, 28, 29]. One of the most common theories used to explain this phenomenon is
what is known as the bystander effect, where irradiated cells release some kind of chemical
signal that causes nearby cells to die, even if they were not irradiated [30, 31]. While the
exact methods of chemical signaling are not relevant to this work, its effect forms one of
the main basis of spatially fractionated radiation therapy. Because of this effect, even when
only portions of the tumor are irradiated, a significant amount of cell death still occurs in
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the tumor. Because tumor tissue experiences greater bystander effects than normal tissue
[32, 33, 34], this gives a radiobiological advantage that allows for preferential killing of the
tumor tissue.
Additionally, other studies have shown a strong dependence of normal tissue recovery
inversly related to field size, where tissue can recover quickly from being irradiated using
a small field (or, as is more likely the case, an array of small fields), even when a high dose
is used[2, 35, 36]. In particular, the work done by Hopewell et al shows that once the beam
diameter is brought below approximately 5 mm, as can be seen in the reproduced Figure
1.2, the healthy tissue tolerance increases almost exponentially.
Figure 1.2: Plot from J.W. Hopewell, K.-R. Trott / Radiotherapy and Oncology 56 (2000)
283-288 [2] From the caption “Animal data showing the influence of field size on biolog-
ical responses in different normal tissues. (A) data for pig skin for: [triangles] the acute
reactions of moist desquamation/acute ulceration; and [circles], late dermal thinning after
104 weeks. ...”
This strong correlation is what influenced the latter part of this work, when the beam
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size was reduced to 2-3 mm in diameter. However, this effect can be reduced when the
surrounding healthy tissue receives some dose, as shown in the work by Bijl et al [3, 4].
In one study, the ED50 for paralysis when irradiating rat spines using a 4 mm wide field
dropped from 53.7 Gy to 39 Gy when the 20 mm surrounding the high dose field was
irradiated with a “shower” of only 4 Gy [4]. This demonstrates that even relatively low
doses delivered to the areas surrounding small fields greatly reduces the radiobiological
advantage of using these small fields by reducing the healthy tissue’s ability to recover.
Also of interest in the same study, the ED50 for an 8 mm length of irradiation increase
from 24.9 Gy to 45.4 Gy when the 8 mm single field was split into two 4 mm fields sep-
arated by 8 mm. [4]. This further reinforces the idea that normal tissue tolerance can be
increased by splitting a single large field in to multiple, smaller fields.
1.5 Monte Carlo modeling and MCNP6
The use of Monte Carlo modeling in areas related to medical physics has a long history,
with papers on electron transport extending back to 1959 [37] and coupled photon/electron
transport going back to 1962 [38]. While the relevant codes have changed over the years,
the basic principles governing the radiation transport of these particles have remained fairly
similar. [39]
For photons, the process is relatively straightforward compared to electrons, in relation
to the relatively few times photons interact with materials when compared to charged parti-
cles. As a basic summary, photon transport is generally done in Monte Carlo codes by first
generating some path-length to the first (or next) interaction site (generally calculated us-
ing a function that includes the mean free path of the photon in the material and a random
number). The particular interaction that occurs is then generated by randomly sampling
from the probability distribution given by the relative interaction probabilities. Finally, the
particulars of the interaction are generated using the relative probability distributions (the
scatter angle for Compton scattering using the Klein-Nishena cross-section, for example).
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For simple simulations, the energetic electron resulting from the interaction is assumed to
deposit its energy locally to eliminate the need to simulate secondaries, though this approx-
imation becomes more and more inaccurate as the photon energy increases and/or the tally
volume decreases. [40] Luckily for the photon simulations done in this work, the maximum
secondary range is small compared to the dimensions of the tally volumes, meaning this
approximation can be used. Regardless, the transport process is repeated for the photon
until some termination criteria is met, usually an energy cutoff and/or a geometric limit.
For electrons, the collapsed history approach first introduced by Berger in 1963 [41]
has remained relatively unchanged, even through to MCNP6 [5]. Instead of modeling each
individual Coulomb scatter event for the electron, something that would quickly become
prohibitively computationally expensive, a type of random walk approach is used, where
each “step” of the walk includes the contributions from many interactions. In brief, some
walk distance is chosen (for MCNP6, this distance is energy dependent, with a larger dis-
tance used for higher energy electrons), and the electron is moved this distance through
the medium. The energy lost during this distance and the new deflection angle are then
generated using the random sampling approach central to Monte Carlo, using a probability
distribution generated by the relevant multiple-scattering theory. For example, for energy
loss, either the continuous-slowing-down approximation, the fluctuation of ionization loss,
or the fluctuation of ionization and bremsstrahlung loss could be used, depending either on
the implementation (which may chose a single method for all electrons) or properties of
the electron (the the fluctuation of ionization and bremsstrahlung loss would make more
sense for a high energy electron moving through a high Z medium due to the significant
contribution of radiative losses). [41] Again, this process is then repeated for the electron
until it meets some criteria for termination.
As mentioned, by modeling coupled photon/electron transport, it is possible to accu-
rately model the majority of radiation treatment modalities used today (with the notable
exception of heavy charged particle treatments, though again these can be simulated in a
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manner similar to electrons). In fact, Monte Carlo methods have been used in several treat-
ment planning scenarios, with the main limitation to implementation the calculation time
needed by these systems. However, with the development of both faster computers and
more efficient MC codes, the use of these types of systems is growing. [42]
MCNP6, or Monte Carlo N-Particle, is a particular implementation of Monte Carlo ra-
diation transport developed by Los Alamos National Laboratory. While not initially devel-
oped for use for treatment planning, MCNP has proved effective for a variety of treatment
planning cases, including 192Ir brachytherapy [43], 60Co teletherapy [44], and as a double
check for a conventional treatment planning system [45], and has been experimentally ver-
ified in innumerable other studies. Because of this, MCNP6 is a strong choice of Monte
Carlo code for this work.
1.6 Film dosimetry and EBT3 radiochromic film
In cases where high resolution dosimetry needs to be done, such as for small fields or
in high-gradient regions of radiation beams, radiochromic film has become the standard
tool used to make these measurements. [46] With a spatial resolution down to 25 µm,
it is easy to overcome the volume effects and relatively poor resolution encountered when
using ion chambers or even diode detectors. GafChromic EBT3 film (produced by Ashland,
Covington, KY), the film used in this work, is constructed as a thin active layer sandwiched
in-between two transparent polyester bases, as shown in Figure 1.3.
While the film is optimized for doses between 0.2 Gy to 10 Gy, by utilizing all three
color channels, the film has a dynamic range of 0.1 to 20 Gy [47], and both limits of this
range will be tested in this work.
Due to the small beam sizes used in this work, with the smallest experimental beam
having a diameter of only 3 mm, using radiochromic film was necessary to take accurate
physical measurements.
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Figure 1.3: Diagram of EBT3 construction, taken from the EBT3 user manual [47]. The





While MV GRID has proven to be clinically useful, it still suffers from some limitations
that we hoped to alleviate by using electrons. To start, while the skin tissue at the beam
entrance tumor is able to recover well from the high dose delivered due to the spatial frac-
tionation, organs behind the tumor may not fair so well. This requires some care be taken
when choosing the beam angle, and could prevent the treatment of tumors located near cer-
tain OARs. However, electrons, with their limited range, would be able to treat these cases
with little worry about exit dose.
Additionally, while MV GRID therapy has shown positive results while leaving some
of the tumor tissue unirradiated, clinical outcomes could potentially be further improved if
a more uniform dose could be delivered to the tumor while maintaining the spatial fraction-
ation in the healthy tissue on the surface. As electrons undergo significant lateral scattering
(compared to photons) uniform tumor dose can be achieved with electrons of the proper
energies.
While some past work has been done looking at electron GRID, all these works either
looked at lower energies[48, 49] or hole sizes 1.5 cm and larger [50], which would limit
the maximum treatment depth and radiobiological benefit, respectively.
2.2 Methods
While working on developing the electron GRID, an initial attempt was made to conduct
some Monte Carlo simulations using MCNP6. However, a number of issues made these
simulations more time intensive than simply taking physical measurements. To start, elec-
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tron transport in MCNP6 is relatively slow due to the large number of interactions that
electron undergo compared to neutral particles. While a neutral particle like a photon or
a neutron will generally only undergo several collisions or interactions, each of which re-
moves a significant portion of the particle’s energy, electrons continuously lose energy as
they travel though a large number of Columbic interactions. Typically, these interactions
are grouped via the collapsed history approach used by MCNP6, where the expected value
of the total energy loss and scatter angle are calculated for all interactions that occurred
within some track-length instead of for each individual interaction, which lowers the com-
putational cost of electron tracking. However, due to the high spacial resolution needed
for these simulations given the small beam size, this collapsed history distance needed to
be reduced such that several of these collapsed history lengths could fit into each voxel.
With a voxel size of 0.5x0.5x0.5 mm, this required a small collapsed history length and
therefore a large increase in the number of interaction sites that needed to be simulated.
This was particularly an issue since the electron source was a linac and therefore had to
be placed approximately 100 cm from the phantom surface in order to give an accurate
representation of the beam divergence. Even with these approximations, each simulation
took almost a month of computer time (and due to how MCNP calculates mesh tallies, they
could not be multi-threaded). GEANT4, another Monte Carlo code, has been shown to be
somewhat faster for charged particle transport and coul be a better choce for future simula-
tions, but the computational times would still have been long. As such, it was determined
that it would be more efficient to simply choose three beam sizes and spacings based on the
literature and take measurements using radiochromic film to evaluate the dose distribution.
The selected beam sizes were 5, 10, and 15 mm with center-to-center spacings of 10, 20,
and 30 mm, respectively. The 15 mm hole size was selected to match the smallest hole
sized currently seen in the literature (Meigooni et al[50]), the 10 mm to be in line with the
standard MV GRID hole size for a physical collimator [18], and 5 mm to investigate hole
sizes smaller than used in current practice.
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2.2.1 Experimental measurement
In order to create an array of beamlets, three aluminum collimators were fabricated, each
with a different hole diameter, as shown in Figure 2.1.
Figure 2.1: Aluminum collimators fabricated for use in film irradiations. Each collimator
was made to fit into the 10 cm x 10 cm cone. Starting on the top and moving clockwise,
the hole diameters are 5, 10, and 15 mm, respectively.
While cerrobend is typically used for electron cutouts, aluminum was chosen as the
collimating material for this case as it is much easier to machine (cerrobend contains several
heavy metals, including lead, which cannot be machined in the Georgia Tech machine
shop). Additionally, as a low Z material, the use of aluminum also reduced the production
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of bremsstrahlung photons. These collimators slotted into the 10 cm x 10 cm electron cone,
as can be seen in Figure 2.2.
Figure 2.2: 15 mm hole collimator in position for irradiation.
The collimators were designed to have 5, 10, or 15 mm diameter holes arranged in a
hexagonal array, with a center-to-center spacing corresponding to twice the hole diameter
(10, 20, and 30 mm respectively). Due to restraints on what could be manufactured, the
holes were not made to be divergent as is typically used in GRID collimators.
To set up the irradiation, first four, 30x30x5 cm blocks of solid water were positioned
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vertically on the treatment couch and aligned along the crossline laser. The accessory
mount and the 10 cm x 10 cm electron cone were then mounted onto the treatment head.
The elevation of the couch was then adjusted such that the top of the solid water was at
100 cm SSD (source to surface distance). The film was placed vertically in the middle
of the solid water such that it extended through the middle of the beam and the top edge
of the film was made to be flush with the top of the solid water. The film was attached
with painters tape, and marks were made to show the position of the film so that future
films could be precisely positioned in the same location, as shown in Figure 2.3. The other
half of the solid water was then moved so that it was again flush with the rest of the solid
water and tightly sandwiching the film. After a final verification of the alignment, the 0.5
cm diameter hole aluminum collimator was positioned in the electron cone. The film was
then irradiated to 600 MU at a rate of 600 MU/min at an energy of 22 MeV. Afterward,
the irradiated film was removed and a new film was put into its place. This process was
repeated for 18 MeV and 15 MeV electrons and for the 10 mm and 15 mm collimators.
Figure 2.3: Film in position for irradiation with one side of the phantom removed. Solid
water on either side provides scatter that one would expect to see in a patient.
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The films were then digitized by scanning them using an Epson 11000xl scanner located
at Emory University Hospital. A custom MATLAB (MATLAB R2018b, The MathWorks,
Natick, 2018) script was used to align and crop the images so they could be more easily
compared to each other and to GRID dose distributions from the literature.
2.2.2 Film calibration
In order to relate the change in the optical density (OD) to the absorbed dose in gray (Gy),
the film must first be calibrated. While this is a simple process, it must be done for each
batch of film as every batch can vary in how it responds to receiving dose. There are
different methods for calibrating these films, but the method outlined below was chosen as
it was the closest to the experimental setup and used a small amount of film. To calibrate the
film, the solid water was arranged in the same geometry as the experimental measurements.
For each energy, a film was irradiated with an open 10 cm x 10 cm field to 600 MU at a
rate of 600 MU/min. Since films have a slight energy dependence and a non-linear dose
dependence, it was important to create a calibration film for each energy and to irradiate
them to the same dose as the test films. The films were also digitized using the Epson
11000xl scanner located at Emory hospital. While software does exist to read and analyze
film, a custom written MATLAB code was used instead as it made comparisons to the
MCNP6 simulations easier. In this setup, the film measurement is highly similar to beam
measurements that were taken during the commissioning of the beam (commissioning was
done using a water tank instead of solid water, but solid water is a comparable substitute).
Because of this, the commissioning percent depth dose measurements (PDD) can be used
to determine the dose at any given depth using the MU to Gy conversion formula:
Dose(Gy, d) = #ofMU ∗Outputfactor ∗ PDD(d) (2.1)
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Since a 10 cm x 10 cm field was used instead of the calibration field size of 15 cm x 15 cm,
an output factor correction is needed, but no other corrections, such as inverse square or
off-axis factor, are necessary. Using these known doses, it was then possible to create a cal-
ibration curve to convert between OD and dose. OD values were sampled every 3 mm from
the film image (corresponding to the data points from the beam commissioning data) and,
using the known dose at these depths, a curve was fitted using the vendor recommended
equation below [47].
d(D) = a+ b/(D − c) (2.2)
where d(D) is the OD of the film at dose D and a,b,c are fitting parameters.
Because of the slight energy dependence of the response of the film, calibration films
were created for each energy used (15, 18, and 22 MeV). Each film was irradiated to the
same 600 MU at a rate of 600 MU/min as the experimental films to ensure there was no
change in the films response to higher dose levels.
2.3 Results and discussion
Films were exposed using each of the three collimator sizes and using both 18 and 22 MeV
electrons. Initially, 15 MeV electrons were also used, but it quickly became clear from a
cursory look at the films that the range of these electrons would not be clinically useful.
Figure 2.4 shows and example of one of the calibration films and the resulting calibration




Figure 2.4: 22 MeV calibration film (a) and the resulting calibration curve (b) using the
calibration formula provided by Ashland.
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Figures 2.5-2.7 show the results for 18 MeV electrons. For the 5 and 10 mm holes
(Figures 2.5 and 2.6, a ”doming” of the dose can be seen because the collimator holes did
not follow the divergence of the beam and more electrons could make it through the center
holes compared to the holes on the edge. A slight misplacement of the collimator also
caused a skew in the dose towards the right of the film. Imperfections in the film at the
edge also resulted in some areas being read as negative dose.
Figure 2.5: Film measurement results from using 18 MeV electrons with the 5 mm hole
size collimator.
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Figure 2.6: Film measurement results from using 18 MeV electrons with the 10 mm hole
size collimator.
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Figure 2.7: Film measurement results from using 18 MeV electrons with the 15 mm hole
size collimator.
Figures 2.8-2.10 show the comparable results for 22 MeV electrons, which are similar
to the 18 MeV case but with more dose delivered to deeper depths.
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Figure 2.8: Film measurement results from using 22 MeV electrons with the 5 mm hole
size collimator.
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Figure 2.9: Film measurement results from using 22 MeV electrons with the 10 mm hole
size collimator.
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Figure 2.10: Film measurement results from using 22 MeV electrons with the 15 mm hole
size collimator.
As seen in Figures 2.11 and 2.12, the smaller hole sizes caused the dose distribution to
shift towards the surface when compared to an open beam; D80, depth of 80% dose, is 6 or
7 cm for 18 and 22 MeV electrons respectively for an open beam, while for the 5 mm hole
collimator, this is reduced to 1.8 and 2 cm, respectively.
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Figure 2.11: Depth dose curves for each collimator compared to the 10x10 open field for
18 MeV electrons. The dose curve for the 15 mm collimator appears to be shifted, which
may be the result of a misalignment of the film when it was placed or when it was scanned.
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Figure 2.12: Depth dose curves for each collimator compared to the 10x10 open field for
22 MeV electrons.
The doming from the beam divergence and the asymmetry from the misalignment were
both greater than expected. In particular, while the positioning of the collimator in the
electron cone was precise enough that no misalignment was noticeable during a visual
inspection, there was a 30% difference in dose at 2 cm for the 5 mm hole collimator between
the rightmost and leftmost beams for the 22 MeV electron beam.
Figures 2.13-2.18 show cross-sectional (crossline) slices of the dose distribution along
with plots of the PVDR as a function of depth for the 18 and 22 MeV cases. For all of
these, the max PVDR is defined as ratio between the dose rate of the central peak divided
by the dose rate of the valley closest to the center, while the mean PVDR is the average
dose rate of the peaks divided by the average dose rate of the valleys. The PVDR shows a
strong dependence on the beam diameter (or perhaps more accurately, the center-to-center
spacing which happens to be proportional to the hole diameter), with relatively low values
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for the 5 mm holes (a max of 2.5 and 2.2 for the 18 and 22 MeV cases, respectively) and
higher values for the 15 mm beams (7.5 and 5, for 18 and 22 Mev, respectively). In all




Figure 2.13: Cross-sectional dose distributions at various depths (a) and the PVDR as a




Figure 2.14: Cross-sectional dose distributions at various depths (a) and the PVDR as a




Figure 2.15: Cross-sectional dose distributions at various depths (a) and the PVDR as a




Figure 2.16: Cross-sectional dose distributions at various depths (a) and the PVDR as a




Figure 2.17: Cross-sectional dose distributions at various depths (a) and the PVDR as a




Figure 2.18: Cross-sectional dose distributions at various depths (a) and the PVDR as a
function of depth (b) for 22 MeV electrons through the 15 mm collimator.
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From both the cross-sectional and PVDR plots, it can be seen that the electron beams
begin to lose definition rapidly upon entering the water phantom, creating a relatively ho-
mogenous dose distribution at deeper depths. Even at the surface, the PVDR is fairly low,
and only exceeds the PVDR for standard GRID photon treatments (5) in three cases; the 10
mm collimator for 18 MeV and the 15 mm collimator for both energies. The PVDRs for the
22 MeV cases are lower that those for the 18 MeV cases primarly due to the higher valley
doses found in the former. This is likely due to increased leakage through the collimator
(from electrons deflected to such an angle where they do not pass through the full thickness
of the collimator) and/or increase bremmstralung contamination.
2.3.1 Conclusions
While the electron dose distributions perform well in two of the target areas, relatively uni-
form dose distribution at the target depth and low exit dose, it is unlikely that this method
could ultimately be used for clinical treatments. One area of concern is the PVDR; as
mentioned, the PVDR is lower than that found in MV GRID treatments for all but a few
of the conditions. This alone is not enough to disqualify this method of electron GRID
treatment, as clinical experience has shown that MV GRID does show clinical benefit even
with PVDRs of only 5, and larger center-to-center spacings could be used to increase the
PVDR. However, the dose rate fall-off as a function of depth is also higher for electrons
when compared to MV beams, something that would likely be exacerbated by increasing
the hole spacing. As a result, the dose rate in-beam quickly (within 5 cm of the surface)
becomes comparable to the ”shielded” dose rate at the surface. This would mean that, for
any treatment volume that extends deeper than 5 cm, the entire surface would necessarily
receive a clinical dose of radiation, which would severely inhibit the recovery effects that
are the reason one would use GRID therapy. Considering that GRID therapy is character-
istically used for bulky tumors, it is unlikely that a tumor that would benefit from GRID
therapy would be less than 5 cm in thickness. This dependance of the effective treatment
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depth on the beam diameter also indicated that reducing the beam diameter below 5 mm
would not be practical.
It is possible that having a divergent collimator could alleviate some of these issues. The
use of a divergent collimator would flatten the dose distribution by reducing the electron
loss through the peripheral holes, which also would increase the dose rate at deeper depths.
However, to properly match the divergence one would need a separate collimator for each
energy and cone size, as the “virtual source point”, and therefore the divergance angle, is
dependant on both of this factors. Additionally, the collimator could then be made to be
somewhat thicker, which could lead to better shielding and therefore better PVDRs near the
surface. Creating a collimator with such holes is difficult, however, and the improvements





With the electrons applications limited to highly specific cases, and with the inability to ef-
fectively reduce the beam size below the 5 mm diameter limit recommended by Hopewell
et al [2], a different radiation source was needed to produce small and clinically useful
beams. Photon-emitting radioisotopes seemed to be the best next option for a variety of
reasons. First, modern radiotherapy linear accelerators almost never go below 6 MV for
their photon energies. With the small beam diameter and center-to-center distances (rela-
tive to current MV GRID treatment) the leakage between beams due to energetic Compton
electrons would be too high, resulting in poor PVDRs. While lower energy linear accelera-
tors are technically feasible and would give some advantages (explored in the next chapter),
we determined that a gamma-emitting radioisotope based approach would be and option.
The thought was also that if the isotope system proved to be effective, it could be devel-
oped into a treatment system with a low upfront cost when compared to linear accelerators,
which could then be used to administer effective radiation treatments in currently under-
served areas. Also, from a research perspective, it would be much easier to gain access
to a radioisotope source to perform verification measurements compared to a low energy
MV system. The physical size of the source could also be set to the same diameter as the
collimator hole to easily create a beam of the desired size. As shown in the electron mea-
surements, if the holes in a collimator used with an accelerator do not accurately match the





The first, and arguably the most important, parameter that was set was the particular ra-
dioisotope that would be used as the gamma source. Due to the limited number of gamma
emitters with useful photon energies and reasonably long half-lives, only three main iso-
topes were initially investigated; Co-60, Cs-137, and Ir-192. While it has been commonly
used as a teletherapy source, Cs-137 was quickly eliminated for two major reasons; its low
specific activity and radiological safety risk. As the desired beam diameter was only 3 mm,
the isotope used must have a high enough specific activity to deliver a clinically useful dose
rate even with such a small source size. Cesium, in the commonly used form of CsF, is also
relatively easy to disperse, making it a less than ideal source from a radiological safety
standpoint. While cobalt has a higher specific activity than cesium, its high energy photons
make shielding requirements are significantly higher compared to the other two sources.
This is particularly an issue with regards to the collimator thickness in the direction of the
patient. More collimator material is needed in order to adequately shield the regions out
of the beams, but the further the sources are moved from the patient, the lower the beam
intensity (and therefore the dose rate) due to the 1/r2 drop off. The high energy photons
would also lead to poor PVDRs. Despite these disadvantages, 60Co, it was still considered
as a viable option. 192Ir’s high specific activity was predicted to give a high dose rate even
with a physically small source, though its correspondingly short half life would necessitate
frequent replacement of the sources in a treatment device. The major advantages of 192Ir
are from its relatively low mean gamma energy of approximately 350 keV, which requires
much less shielding and also leads to higher PVDRs.
With the sources set, it was then possible to start investigated other necessary param-
eters, such as the collimator material and thickness, and the center-to-center spacing of
the beams. To predict the effects of changing these various parameters on the resulting
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dose distributions without needing to physically construct a wide variety of collimators,
MCNP6 was used to model various conditions. To further decrease the number of vari-
ables that needed to be changed, the collimator hole diameter was set at 3 mm (though this
was later changed to 2 mm) and the source thickness was set such that self attenuation was
capped at 50%; that is, that half of the photons produced in the top of the source would be
expected to make it through the source into the collimator holes. This corresponded to a
thickness of 2 mm and 15 mm for the 192Ir and 60Co sources, respectively.
3.2.2 MCNP simulations of isotope minibeams
3.2.2 Parallel minibeams
The geometric configuration of the parallel minibeams and the water phantom included in
the MCNP6 simulations is shown in Figure 3.1. As shown, there are seven minibeams
with their corresponding sources arranged in a hexagonal geometry. The source and the
collimator hole have the same diameter of 3 mm. In order to compare different collimator
designs, each design was assessed based on its PVDR at the surface and its dose rate at a
depth of 10 cm. As a minimum requirement, the collimator would have to allow a dose
of 20 Gy to be delivered to a depth of 10 cm while not exceeding a dose of 1 Gy in the
valley region at the surface. This requirement was based on a combination of the maximum
single fraction dose typically used in standard GRID therapy and the study by [4] showing
decreased tissue recover for valley doses above 1 Gy.
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Figure 3.1: The geometric configuration of the parllel minibeams and the water phantom
that were included in the MCNP6 simulation.
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Initially, all simulations were done using a type 3 superimposed mesh tally, which mea-
sured the energy deposited in an array of 0.5×0.5×0.5 mm voxels (units of MeV/cm3/source
particle) which could be easily converted to a dose rate (using the density of water and the
activity of the source, this can be converted to Gy/min using the Equation 3.1.
Ḋ = M ∗ ρ ∗A(Ci) ∗ 3.7× 1010Bq
Ci







Where M is the tally result, ρ is the density of the tally material, A is the activity in Curies,
and y is the mean photons per decay of the radioisotope.
Because of the radial symmetry of the collimator, only two beams needed to be sim-
ulated per collimator; one in-plane and one out-of-plane (i.e. the solid beams shown in
Figure 3.2). The other beams could then be accounted for using shifts corresponding to the
chosen center-to-center distance. While this approach gives an excellent visualization of
the dose distribution, it has significant drawbacks. Because of the small size of the voxels
needed to give sufficient spatial resolution to adequately represent the lateral dose profile
of the minibeams, a large number of particles need to be run to reduce the uncertainty to
an acceptable level, especially in the valley region. Since this would require an unaccept-
able amount of computer time, a different approach was needed in order to optimize the
collimator parameters.
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Figure 3.2: Cross-sectional view of simulated beam geometry at the source plane. Solid
beams were simulated for both the parallel beam and converging beam geometries, while
the hashed beam was additionally simulated for the converging beam geometries.
Again making use of the radial symmetry of the collimator, a series of concentric ring
tally volumes (with radii corresponding to half the source radius, half the center-to-center
distance, and the full center-to-center distance) were used at specific depths instead of
using the superimposed mesh. Using this geometry, 10 collimator thicknesses (4 to 9 cm,
steps of 0.5 cm) and 8 center-to-center distances (6 to 14 mm, steps of 1 mm), and two
collimator materials (tungsten and brass) were investigated, for a total of 160 combinations.
In addition, F6 (i.e. kerma) tallies were used instead of +F6 (i.e. the absorbed dose tally)
in the valley region. The combination of using larger tally volumes and F6 tally drastically
reduced the uncertainty of the valley dose from 40% to approximately 3% with 107 particle
histories. The use of F6 tally was justified by the fact that the range of the Compton
electrons is mostly shorter than the tally size.
3.2.2 Convergent minibeams
The geometric configuration of the convergent minibeams and the water phantom that were
included in the MCNP6 simulation is shown in Figure 3.3. In this simulation, the same
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collimator thickness and material were used as in the parallel beams. However, a new
center-to-center distance was needed to account for the new beam orientations. For the
convergent case, the premature intersection of the beams due to the beam divergence was
more of a concern when picking the center-to-center distance than the PVDR. Since the
effective center-to-center distance changes as a function of depth for the convergent beams,
the ring volumes used in the previous geometry needed to be modified to account for this.
Two additional tally volumes were also included, one at 9.5 cm and one at 10.5 cm, to
verify that the highest dose rate was indeed being delivered to the target depth of 10 cm.
A diagram of this geometry can be seen in Figure 3.3. Again, taking advantage of the
symmetry of the problem, only three beams needed to be simulated to calculate the full
dose distribution: the central beam , an on-plane diagonal, and an off-plane diagonal (i.e.
the two solid and one hashed beams shown in Figure 3.2).
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Figure 3.3: Convergant geometry collimator. As with the parallel case, the collimator thick-
ness, center-to-center distance, and hole diameter were all varied throughout the course of
this work.
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3.2.3 Maximum achievable activity
One important parameter for determining the dose rate is the maximum achievable activity,
or MAA, of the sources. 192Ir is produced by exposing 191Ir to a high thermal neutron flux
in a nuclear reactor. Because a non-negligible fraction of the 192Ir produced will decay or be
converted to 193Ir while the source is still being irradiated, the MAA for 192Ir corresponds
to when the production rate and the depletion rate of the 192Ir are equal. The amount of
192Ir present in a source can be calculated as a function of irradiation time and neutron flux
using Equation 3.2:
N192(ti) ∼= N192(ti−1) +N191(ti−1)σ191φn∆t−N192(ti−1)(λ192 + σ192φn)∆t
= N191(ti−1)σ191φn∆t+N192(ti−1) [1 − (λ192 + σ192φn)∆t]
(3.2)
Where N191 and N192 are the number of atoms of 191Ir and 192Ir, respectively, at a given
time point, either the previous time step ti−1 or current time step ti with a step length of
∆t, σ191 and σ192 are the microscopic thermal absorbtion cross-sections of 191Ir and 192Ir,
respectively, and λ192 is the decay constant for 192Ir.
Using Equation 3.2, one can find the MAA and necessary irradiation times for the
thermal neutron fluxes found in various isotope production reactors. While Equation 3.2
is also applicable to convert a sample of Co-59 to Co-60, the time needed to reach MMA
for 60Co is too long to be practical. This is mainly due to the long half life of 5.2 years
for 60Co. Because of this, the maximum irradiation time for producing high activity 60Co
sources was set to sixty days.
3.2.4 Shielding calculations
As an exercise to demonstrate the feasibility of storing such high activity sources in a
hospital, simulations were done to find what size of lead pig would be needed to reduce
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the dose rate to below 5 mrem/hr one foot (30 cm) from the surface of the container. This
level was chosen as it is the threshold for an area being classified as a radiation area. The
more conservative public dose limit of 2 mrem/hr was not used as it was assumed anyone
entering the room would be hospital personnel with personal dosimetry or a patient who
is about to undergo treatment. An F5 tally was used to minimize the computational time
needed to run the shielding simulations.
3.2.5 Physical measurements
To try to verify the 192Ir simulations, physical measurements were conducted using an
192Ir HDR source at Cancer Centers of America’s facility in Newnan, Georgia to com-
pare against MCNP6 simulations of the same geometry using the same tally types and the
same source parameters (where applicable). The HDR system was a Varisource iX (Varian,
Palo Alto, CA) Two tungsten collimators were fabricated (that is, 3 mm holes were bored
through two pieces of tungsten), each with a thickness of 3 cm. From the simulation, a
single piece of tungsten was deemed sufficient to produce a nicely collimated beam, and
the use of a single collimator eliminated the potential error from a misalignment. By at-
taching a guide tube to the collimator, it was possible to position the source above the hole
to approximate the geometry of the proposed GRID collimator design. The dummy source
from the afterloader was used to find the source position needed to center the source above
the hole. The actual experimental setup is shown in Figure 3.4.
Using the dose rates obtained from the simulation, the source was placed in the active
position (that is, centered above the collimator hole) for a total of 7792 seconds, which was
calculated to deliver 20 Gy to Dmax, the maximum dose to which the film was sensitive.
This was done to maximize the dose in the valley region in an attempt to bring it above the




Figure 3.4: Set up for the 192Ir measurements. (a) shows the alignment of the HDR guide
tube with the 3 mm diameter hole in the collimator. (b) shows a zoomed out view of the
setup, including the afterloader.
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The OD of the film was converted to dose using the commercial software FilmQA Pro
(Ashland Inc., Covington, KY). A set of 7 calibration film strips were produced using the
Varian iX linear accelerator at Georgia Tech, using doses of 0.0, 0.5, 1.0, 4.0, 8.0, 16.0, and
20.0 Gy. These values were selected both to cover the full range of doses expected on the
experimental film and to increase (roughly) exponentially to provide better data points for
the fit. The OD to dose conversion formula is below:
d(D) = a+ b/(D − c) (3.3)
where d(D) is the OD of the film at dose D and a,b,c are fitting parameters.
Figure 3.5 shows the calibration process, with the calibration film loaded into FilmQA
Pro. As can be seen in the figure, each color channel has a different response function. In
general, the red channel is the most accurate for low doses, the blue channel for high doses,
and the green for doses between the two extremes.
Figure 3.5: Calibration film loaded into the film reading software FilmQA Pro. The center
window shows the calibration film which provides 7 calibration points used to generate the




3.3.1 Maximum achievable activities
Figure 3.6 shows the time-dependent growth and depletion of the quantities of 191Ir and
192Ir inside a nuclear reactor based on a flux (φn) of 1.0x1015 neutrons cm−2 s−1. As shown,
tmax for 192Ir is around 230 hours ( 9.5 days). Table 3.1 shows the MAAs cm−3 of 192Ir
for φn ranging from 1.0x1014 to 2.0x1015 neutrons cm−2 s−1 as well as the corresponding
tmax. As shown, both the MAA and the corresponding tmax vary with φn. Specifically,
the MAA increases as φn increases and it is also achieved with a shorter irradiation time,
tmax. As such, high flux reactors are favored over the low flux reactors to produce higher
activity 192Ir sources and with a shorter turnaround time. If one takes the nominal φn of
1.0x1015 neutrons cm−2 s−1, which is available at the High Flux Isotope reactor (HFIR) at
the Oak Ridge National Laboratory (ORNL) [17], and the feed material with an initial 191Ir
atomic number density of 5.69x1022 atoms cm−3, Table 3.1 shows that the MAA cm−3 of
192Ir is 1.765x109 MBq and it is achieved with merely 9.5 days in the reactor. Accordingly,




π(0.15cm)2(0.2cm) = 2.495 × 107MBq ∼= 674.3Ci.
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Figure 3.6: Time-dependent growth and depletion of the quantities of 191Ir and 192Ir inside
a nuclear reactor based on φn of 1.0x1015 neutrons cm−2 sec−1.
Table 3.1: The MAAs cm−3 of 192Ir and the corresponding irradiation times for various
thermal neutron fluence rates.








3.3.1 Minibeam dose distributions obtained from MCNP6
Ultimately, none of the brass collimators were able to give sufficiently high PVDRs at the
surface and a high enough in-beam dose rate at 10 cm depth to deliver 10 Gy to a target at
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10 cm depth while delivering less than 4 Gy to the valley region at the surface. Because
of this, tungsten was used as the sole collimator material. For tungsten, the ideal thickness
was found to be 5.5 cm, as any increase past point reduced the dose rate while only giving a
negligible increase in the PVDRs. The following results all use these collimator parameters.
Using the 192Ir activity obtained in the previous section, it is possible to calculate the
dose rate and dose distribution in the water phantom. Figure 3.7 shows dose distribution
from a single beam. By using superposition, it was possible to use this distribution to
construct the expected dose distributions from using different center-to-center distances, an
example of which can be seen in Figure 3.8. While this method gives a good visualization
of the dose distribution, it can not be used to calculated the PVDR, as the low relative
photon fluence in the valley leads to high error (>30%) in this region (compared to the
<2% error in beam). As mentioned in the methods section, this problem was solved by
using concentric ring tally volumes. The PVDRs for different center-to-center spacings




Figure 3.7: MCNP6 results of the single 3 mm minibeam characteristics for 192Ir: (a) the 2-





Figure 3.8: MCNP6 results of the superposition of 7 parallel 3 mm 192Ir minibeams with
a c-t-c of 8 mm : (a) the 2-D in-phantom dose profile, and (b) the cross-sectional dose
distributions
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Table 3.2: The PVDRs at various depths in the water phantom produced by a hexagonal
array of parallel 3-mm (in diameter) 192Ir minibeams of various c-t-c distances.
Depth in phantom (cm)
PVDR
6 mm c-t-c 8 mm c-t-c 10 mm c-t-c 12 mm c-t-c
0.5 26.2 58.8 90.8 182.4
2.5 2.7 17.5 31.1 56.9
5.0 0.77 2.3 10.4 27.7
7.5 0.67 0.94 2.1 15.0
10.0 0.96 0.75 1.1 7.0
Table 3.3: The dose rates at various depths in the water phantom produced by a hexagonal
array of parallel 3-mm (in diameter) 192Ir minibeams of various c-t-c distances.
Depth in phantom (cm)
Dose Rate (Gy/min)
6 mm c-t-c 8 mm c-t-c 10 mm c-t-c 12 mm c-t-c
0.5 8.24 8.14 8.11 8.10
2.5 3.88 3.85 3.87 3.78
5.0 1.87 1.82 1.81 1.73
7.5 1.14 0.97 0.94 0.86
10.0 1.01 0.57 0.52 0.46
Compared to the electron GRID investigated earlier, the 192Ir minibeams offer a marked
increased in PVDR, though a similarly sharp drop of the dose rate with depth. The reason
for this drop off is different however; for the electrons, it is caused primarily by lateral
scattering by the electrons out of the main beam-line while for the 192Ir beams it is caused
primarily by the 1/r2 effect. With the collimator placed 0.2 cm from the surface and a




≈ 6.41, while the ratio for an accelerator based system with





≈ 1.21. While this does not account for the full drop-off (using a





2.83), it is a major contributing factor. Increasing the distance between the collimator and
the phantom surface would decrease the dose fall off in the phantom, but at the cost of
decreasing the already low absolute dose rate and increasing the spot size at the surface.
On the topic of spot size, it can be seen from Figure 3.7 that even though the collimator
hole size is 3 mm, the beam FWHM at the surface is about 5 mm, which was identified
as the largest hole diameter thought to still give a significant radiobiological advantage.
Because of this, these results were re-run using a 2 mm source and hole size to decrease
the spot size at the surface.
3.3.1 Reduced source size, Ir-192
The main result of this reduction in size was a decrease in the total activity of each 192Ir
source. From the reduction in source volume, the source activity changed from 674.3 Ci to
299.7 Ci. Additionally, the range of c-t-c spacings investigated was changed from 6, 8, 10,
12 mm to 4, 6, 8, 10 mm to account for the smaller hole size. Other than these changes, the
simulations and analysis were conducted identically to those run previously.
Figure 3.9 shows the single beam 2D dose distribution and PDD for this new geometry,
a parallel to Figure 3.7. As one would expect from the over 50% reduction in source
activity, the dose rate drops by a similar amount, going from about 8 Gy min−1 to 3.5 Gy
min−1 at the surface. However, the spot size at the surface does drop below the 5 mm
diameter limit.
Figure 3.10 shows the results corresponding to Figure 3.8, though using a reduced
center-to-center spacing of 8 mm instead of 10 mm. As with the single beam results, the
main difference is the reduction in the dose rate seen throughout the distribution. Table 3.4
shows the PVDRs for various depths using different center-to-center spacings, while Table




Figure 3.9: MCNP6 results of the single 2 mm minibeam characteristics for 192Ir: (a) the 2-





Figure 3.10: MCNP6 results of the superposition of 7 parallel 2 mm 192Ir minibeams with
a c-t-c of 8 mm : (a) the 2-D in-phantom dose profile, and (b) the cross-sectional dose
distributions
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Table 3.4: The PVDRs at various depths in the water phantom produced by a hexagonal
array of parallel 2-mm (in diameter) 192Ir minibeams of various c-t-c distances.
Depth in phantom (cm)
PVDR
4 mm c-t-c 6 mm c-t-c 8 mm c-t-c 10 mm c-t-c
0.5 26.4 87.24 154.0 210.5
2.5 2.37 29.8 59.5 87.2
5.0 0.78 4.82 24.4 41.4
7.5 0.67 1.30 6.94 21.2
10.0 0.95 0.83 1.90 7.96
Table 3.5: The dose rates at various depths in the water phantom produced by a hexagonal
array of parallel 2-mm (in diameter) 192Ir minibeams of various c-t-c distances.
Depth in phantom (cm)
Dose Rate (Gy/min)
4 mm c-t-c 6 mm c-t-c 8 mm c-t-c 10 mm c-t-c
0.5 3.62 3.60 3.59 3.61
2.5 1.69 1.67 1.68 1.70
5.0 0.81 0.78 0.77 0.77
7.5 0.49 0.40 0.40 0.39
10.0 0.43 0.23 0.22 0.22
3.3.2 Co-60 minibeams
3.3.2 Maximum achievable activity
Similarly to the iridium calculations, the maximum achievable activities were calculated
for a variety of neutron fluxes. Table 3.6 shows these MMAs.
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Table 3.6: The MAAs cm−3 of 60Co and the corresponding irradiation times for various
thermal neutron fluence rates.




Because of the the long half-life of 60Co, reaching the maximum achievable activity
takes considerably longer than for 192Ir, taking at a minimum of 674 days, or almost two
years, compared to the maximum of 71.9 days for iridium. This makes it impractical to aim
for this maximum level of activity. Instead, it is better to chose some reasonable amount of
time, such as 60 days, that provides an acceptable level of activation. Using this irradiation
time of 60 days and a φn of 5.0x1014 n cm−2 s−1 gives a nominal MMA of 1.466x108
Mbq cm−3. Using this and a source size of 3mmx15mm, the activity can be calculated as
1.466 × 108
cm3
π(0.15cm)2(1.5cm) = 1.5547MBq ∼= 420Ci.
3.3.2 Dose distribution
As with the 192Ir, none of the brass collimators were able to give sufficiently high PVDRs
at the surface and a high enough in-beam dose rate at 10 cm depth to deliver 10 Gy to a
target at 10 cm depth while delivering less than 4 Gy to the valley region at the surface.
Tungsten was used as the collimator material though ideal thickness increased to 8 cm.
Again, the MMA can be used to calculate the dose rate and distribution of the 60Co
minibeams. Figure 3.11 shows the dose distribution and the PDD curve for a single cobalt
beam. While the dose rate fall off is still significant, it is not as severe as in the 192Ir
case, likely due to reduce attenuation of the beam because of the higher mean photon
energy. This increased penetrative ability does come with a downside, namely increased
leakage through the collimator leading to a lower PVDR at the surface than the 192Ir case.
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These PVDRs can be seen in Table 3.7, as well as in Figure 3.12, which shows the dose
distribution resulting from the superposition of seven beams. While not nearly as high
as for the iridium beams, the PVDRs are still comparable or greater than those in MV
treatments.
The PVDRs, shown in Table 3.7, are a fair bit lower than those for the comparable 192Ir
case, while the dose rates, shown in Table 3.8, are similar, abet with slightly lower dose




Figure 3.11: MCNP6 results of the single 3 mm minibeam characteristics for 60Co: (a)
the 2-D in-phantom dose profile, and (b) the in-phantom depth-dose distribution along the
beam centerline.
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Figure 3.12: MCNP6 results of the superposition of 7 parallel 3 mm 60Co minibeams with
a c-t-c of 10 mm : (a) the 2-D in-phantom dose profile, and (b) the cross-sectional dose
distributions
Table 3.7: The PVDRs at various depths in the water phantom produced by a hexagonal
array of parallel 3-mm (in diameter) 60Co minibeams of various c-t-c distances.
Depth in phantom (cm)
PVDR
6 mm c-t-c 8 mm c-t-c 10 mm c-t-c 12 mm c-t-c
0.5 9.98 22.02 33.82 44.30
2.5 3.77 12.73 24.00 36.55
5.0 1.22 5.09 12.81 20.87
7.5 0.79 1.90 6.01 12.07
10.0 0.73 1.10 2.55 6.18
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Table 3.8: The dose rates at various depths in the water phantom produced by a hexagonal
array of parallel 3-mm (in diameter) 60Co minibeams of various c-t-c distances.
Depth in phantom (cm)
Dose Rate (Gy/min)
6 mm c-t-c 8 mm c-t-c 10 mm c-t-c 12 mm c-t-c
0.5 7.93 7.68 7.65 7.63
2.5 4.68 4.62 4.61 4.62
5.0 2.78 2.71 2.69 2.69
7.5 1.84 1.70 1.68 1.09
10.0 1.37 1.15 1.09 1.06
3.3.2 Reduced source size, Co-60
As with the 192Ir results above, using 3 mm diameter sources and collimator holes led to a
surface spot size above 5 mm in diameter. Again, the simulations were re-run using 2 mm
diameter sources to reduce the spot size below this threshold. In the case of the 60Co, the
activity per source was subsequently reduced from 420 Ci to 186.7 Ci. And, as with the
192Ir case, the c-t-c spacings investigated were changed from 6, 8, 10, and 12 mm to 4, 6, 8,
and 10 mm. Figure 3.13 shows the new single beam distribution while Figure 3.14 shows
the distribution from the full array of seven beams. The new PVDR and dose rate results




Figure 3.13: MCNP6 results of the single 2 mm minibeam characteristics for 60Co: (a)





Figure 3.14: MCNP6 results of the superposition of 7 parallel 2 mm 60Co minibeams with
a c-t-c of 8 mm : (a) the 2-D in-phantom dose profile, and (b) the cross-sectional dose
distributions
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Table 3.9: The PVDRs at various depths in the water phantom produced by a hexagonal
array of parallel 2-mm (in diameter) 60Co minibeams of various c-t-c distances.
Depth in phantom (cm)
PVDR
4 mm c-t-c 6 mm c-t-c 8 mm c-t-c 10 mm c-t-c
0.5 10.17 34.8 56.1 75.3
2.5 3.37 21.4 44.4 64.4
5.0 1.21 8.96 25.8 42.5
7.5 0.79 3.32 13.4 27.4
10.0 0.72 1.58 6.50 16.4
Table 3.10: The dose rates at various depths in the water phantom produced by a hexagonal
array of parallel 2-mm (in diameter) 60Co minibeams of various c-t-c distances.
Depth in phantom (cm)
Dose Rate (Gy/min)
4 mm c-t-c 6 mm c-t-c 8 mm c-t-c 10 mm c-t-c
0.5 3.41 3.32 3.31 3.31
2.5 2.02 1.98 1.97 1.97
5.0 1.20 1.15 1.14 1.14
7.5 0.79 0.72 0.70 0.70
10.0 0.58 0.47 0.46 0.45
3.3.3 Shielding requirements
The MCNP6 results indicated that, for the maximum activity of 2,100 Ci (i.e. 300 × 7) of
192Ir, 9.6 cm of lead would reduce the dose rate to 4.55 (± 0.21) mrem hr−1 at 30.5 cm (or
1 ft) from the surface of the container. This would make the lead container 31.5 kg, which
should be a manageable weight at a clinical setting.
Comparatively, for the maximum activity of 1306.9 Ci of 60Co, it would take 24 cm of
lead to reduce the dose rate to the same amount. Such a container would have a mass of
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984 kg.
As shielding requirements for the treatment device will likely be similar (to prevent
excess dose outside of the target area), a 60Co system may have to be fixed, much like
current Gamma Knife (Elekta) machines. However, an 192Ir treatment device would be
light enough to mount onto a robotic arm to allow for more flexibility in treatment position,
more similar to a Cyber Knife unit (Accuray).
3.3.4 Film measurements
As mentioned above, the film measurements were converted to dose using the commercial
software FilmQA Pro, produced by Ashland Inc. During the initial comparison, there was
a large discrepancy between the absolute dose measurements from the film and the dose
calculated from the simulations. This was traced back to a geometry error in defining the
source in the MCNP6 input file; the radii of the source and surrounding wire were not
converted from mm to cm. As this geometry was specific to just this test case and not
the other isotope based simulations used in this work, this had no impact on the validity
of the other simulations. After correcting this issue and re-running the simulation, the
discrepancy was greatly reduced, but not entirely eliminated. Several other attempts were
made to eliminate this difference, including changing the tally type to +F6 and tracking
the secondary electrons (in essence, changing from tallying kerma to energy deposited)
and expanding the 192Ir spectrum used to include all lines with yields over 0.1% per decay
(from a simplified spectrum only including lines with yields above 1%). However, none
of these gave results closer to those obtained from the films. Also, the new simulation
revealed that the dose delivered to a depth of 0.5 cm was approximately 48 Gy, well above
the film’s dose limit, so a comparison could no longer be made between the simulation and
the film measurement at this depth.
Even with the remaining discrepancies, the simulated and experimental results align
well, particularly in high dose regions. Comparisons between the simulated and experi-
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Figure 3.15: Comparison of simulation and film doses for the 192Ir physical measurements
at a depth of 25 mm. (a) shows the absolute doses obtained from both methods while (b)




Figure 3.16: Comparison of simulation and film relative doses for the 192Ir physical mea-
surements at a depth of 25 mm. (a) shows the relative doses (normalized to dose at central
axis) obtained from both methods while (b) shows the percent dose difference between the




Figure 3.17: Comparison of simulation and film doses for the 192Ir physical measurements
at a depth of 50 mm. (a) shows the absolute doses obtained from both methods while (b)




Figure 3.18: Comparison of simulation and film relative doses for the 192Ir physical mea-
surements at a depth of 50 mm. (a) shows the relative doses (normalized to dose at central
axis) obtained from both methods while (b) shows the percent dose difference between the




Figure 3.19: Comparison of simulation and film doses for the 192Ir physical measurements
at a depth of 75 mm. (a) shows the absolute doses obtained from both methods while (b)




Figure 3.20: Comparison of simulation and film relative doses for the 192Ir physical mea-
surements at a depth of 75 mm. (a) shows the relative doses (normalized to dose at central
axis) obtained from both methods while (b) shows the percent dose difference between the




Figure 3.21: Comparison of simulation and film doses for the 192Ir physical measurements
at a depth of 100 mm. (a) shows the absolute doses obtained from both methods while (b)




Figure 3.22: Comparison of simulation and film relative doses for the 192Ir physical mea-
surements at a depth of 100 mm. (a) shows the relative doses (normalized to dose at central
axis) obtained from both methods while (b) shows the percent dose difference between the
MCNP6 and the film results.
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There are several potential causes for these discrepancies. The simplest, and most
likely, is some geometric difference between the true experimental setup and the simu-
lation. While as much care was taken to make the set up as exact as possible, based on
the small size of the source and beam, even small deviations in the geometry between the
measurement and simulation could cause noticeable differences. Another possibility could
be an averaging effect caused by the tally volume size in the simulation. While the film has
a high spatial resolution, with a pixel size of 0.17 mm, it is difficult to use tally volumes
this small in the simulation for two reasons. The first is that the smaller the tally volume,
the more difficult it becomes to get good statistics, especially in the valley region where
the photon flux is already low. The other is that, as mentioned earlier, to decrease the er-
ror and drastically increase the run time the simulation is set up to tally kerma instead of
energy deposited directly. While this is a good approximation for larger tally volumes, as
the secondary electron range is small relative to the tally volume, once the tally volume
dimensions approach the electron range, this approximation breaks down.
Overall, the simulations generally appear to underestimate the central axis dose and
overestimate the valley dose. If these same discrepancies hold true for the simulations used
elsewhere in this chapter, then this would mean that the calculated dose rate and PVDRs
would be underestimated. Since the general motivation was to maximize both of these
values, this would imply that the “real” system would outperform the simulations.
3.4 Conclusions
3.4.1 Parallel geometry
While the initial hope was that the maximum achievable activity for each of the sources
would deliver a high dose rate, allowing for the use of lower activity sources to be feasible,
the simulations ultimately showed this to be false. In fact, it appears that even when using
the highest possible source activities, ranging from 200-300 Ci per source, the dose rate is
still not high enough for the parallel geometries for this to be used as a feasible treatment
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technique. From a practicality standpoint, the seven sources need to treat an area with a
diameter of up to 2 cm already would require over a kiloCurie of activity. While less than
the activity contained in a single GammaKnife unit, this would still pose an issue due to
the high activity per source.
Furthermore, even assuming a source could be procured for each beam line, it would
take approximately 25 minutes to deliver 10 Gy to a depth of 10 cm using the 60Co sources
and 50 minutes to deliver the same dose with the 192Ir sources. To avoid blurring the
beams and degrading the PVDR of the treatment, the patient would have to be prevented
from moving even fractions of a millimeter for this duration, a difficult task at best and an
impossible one at worst.
However, an accelerator based approach could potentially avoid both of these issues.
As the beam could be turned on and off, regulatory restrictions would not be as severe
and gating could potentially be used to minimize the effect of motion. The beam current
could also be modulated to adjust the dose rate and, at least for megavoltage beams, the
bremsstralung production would be forward directed. While more difficult from a techni-
cal prospective, these potential advantages prompted investigation into the potential dose
distributions from a 2 MV system.
3.4.2 Convergent geometry
While the parallel geometry produced a sub-optimal dose rate, the convergent geometry
gave dose rates at the target above 3 Gy/min for the 60Co system (while the 192Ir system
gave a respectable dose rate of 1.5 Gy/min, the cobalt system is superior in both the ratio
of dose at the surface to at depth and in the isotope half-life). With a dose rate on par with
GammaKnife and using a similar total activity of cobalt (abet spread across a smaller num-
ber of sources), this system could conceivably be used for SBRT style treatments of small
tumors. There is a potential trade-off between the 192Ir-based and 60Co-based minibeams.
While the 192Ir system requires less shielding, and therefore would be light enough to be
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mounted onto a robotic arm for treatment flexibility (similar to the CyberKnife), the short
half-life of 192Ir requires the sources be replaced every few months. The 60Co system,
while it requires significantly more shielding and likely has to be fixed (similar to the Gam-





While the isotope minibeams did offer a good PVDR at the surface, low dose rate for the
parallel case and the small treatment volume for both cases severely limits the clinical ap-
plications of these designs. Since it would be impossible to remedy these limitations using
a radioisotope, the possibility of using a bremsstrahlung source was also investigated. By
controlling the beam current, one could adjust the dose rate, and changes in the electron en-
ergy could be used to modify the mean energy of the source. As mentioned in the previous
chapter, the use of an accelerator also means the beam could be turned on and off quickly,
which could allow for the treatment to be gated, that is, only have the treatment beam on
when the patient is in a certain position. Doing this could prevent the dose distribution
from becoming blurred by something like respiratory motion, which would help preserve
the PVDR of the treatment.
While 6 MV was the lowest energy bremsstrahlung spectrum physically available, using
MCNP6 it was possible to generate lower energy spectra by simulating a beam of electrons
incident on a custom designed target. Conversely, while it would be relatively easy to con-
duct a physical measurement for a 6 MV beam, creating an accurate beam model (in terms
of energy spectrum and divergence) for the Varian linear accelerator would be highly diffi-
cult, involving careful tuning of the electron energy and of the exact size and composition
of parts in the head of the machine, as Varian does not regularly release this proprietary
information. As this type of work has frequently been the primary focus of publications
or theses [51, 52, 53, 54] and these simulations would not give much more information
compared to the physical measurement, it was deemed beyond the scope of this project.
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4.2 Beam parameter selection
While in the isotope cases, only the collimator parameters needed to be set, for bremsstrahlung
minibeams, the source parameters, such as the electron energy, target thickness, and filter
design also need to be set. While in theory, all of these parameters could be tuned to fully
optimize the PVDR and dose rate, simulating the production of bremsstrahlung photons is
computationally expensive. With the wide variety of combinations possible, I determined
that this optimization was beyond the scope of this work and instead selected values for
each of these parameters based on justifications from the literature, discussed in detail be-
low.
4.2.1 Electron beam energy and current
Arguably the most important parameter, the electron energy used to generate the beam
defines the energy spectrum of the resulting bremsstrahlung photons as well as the photon
yield. As the PVDRs of the isotope treatments were inline with what we hoped, we wanted
something with a similar mean energy to minimize the modifications to the collimator. As
the mean energy of a bremsstrahlung beam is one-third of the maximum energy [55], I
chose a 2 MeV beam, to give a mean photon energy of 667 keV, roughly halfway between
the mean energies of 192Ir and 60Co.
Similar to the maximum achievable activity of the isotope sources, it is important to
find the maximum feasible current that could be used for this type of accelerator to find
the dose rate. As a conservative estimate, the data sheet for the modified Varian Clinac-6
accelerator at the University of Maryland [56]. From the sheet, the 2 MeV beam has a peak
current of 440 mA, with a pulse width of 3 µs and a pulse repetition rate of up to 300 pulses
per second. This gives an effective steady state current of




to be used for the dose rate calculations.
4.2.2 Target and filter thickness
The target material was chosen to be tungsten for the same reasons most bremsstrahlung
targets are made of tungsten; its high Z increases the photon yield for a given photon
energy, and its high melting point means it can absorb the large amount of energy from the
electrons that is not converted to photons. The target thickness was chosen to be 1.1 times
the CSDA range of the electrons. This was chosen to make sure the electrons would be
fully stopped in the target and to give a small degree of filtration. For 2 MeV electrons,
the CSDA range as given by NIST [57] is 1.613 g/cm2 which, using a density of tungsten
of 18.7 g/cm3, gives a range of 0.086 cm and a target thickness of 0.095 cm. For the filter,
little was known about what thickness would be ”optimal” for this type of setup. As the
main concern was reducing superfluous surface dose from low energy x-rays, I determined
that any filter that would cut out these photons would be acceptable. The filter was set to be
2 mm of aluminum, which did a good job of filtering out x-rays below 50 keV, as evaluated
using the spectrum measured using a energy binned F4 tally.
4.3 Geometry
4.3.1 2 MV beams
With the beam parameters set, the next step was to set the geometry for the collimator used
to shape the beams. This collimator design was chosen to be the same as the 60Co, tungsten
of a thickness of 8 cm, to simplify the comparison between the different modalities. As
the 2 MV beam would have a lower mean energy but a higher max energy than the 60Co
source, I determined that this thickness should give comparable levels of shielding. As with
the second stage of the isotope simulations, the beam diameter was set to be 2 mm. The
center-to-center distances evaluated were also the same, 4, 6, 8, and 10 mm, with a 12 mm




Figure 4.1: MCNP geometry for the 2 MV simulations: (a) the main geometry, (b) detail
of the target, (c) detail of the beam exit and (d) detail of the tally volumes. For all images,
blue represents tungsten (target and collimator), yellow represents water, cyan represents
the tally volumes (also water), purple represents air, and green represents aluminum.
The tallies used for the MV case are the same as those used in the isotope case, which
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is to say F6 kerma tallies.
4.3.2 6 MV beam
As the 6 MV portion was a physical measurement instead of a simulation, the geometry
details were more restrained. For the irradiation, both of tungsten collimators that were
initially fabricated for the 192Ir measurements were used. Each collimator is 3 cm thick with
a 3 mm diameter hole. The film setup was almost identical to the electron measurement,
with a piece of radiochromic film sandwiched in the center of 4 30x30x5 cm slabs of solid
water. The setup can be seen in Figure 4.2. The MV imager was used to verify the hole
alignment with the centerline of the solid water prior to the film being placed. The film was
then irradiated using 2000 MU and a 4x4 cm field. The field size was chosen to not extend
beyond the edges of the collimator and is the smallest field size for which there is a MU
to dose conversion factor given in the calculation book created when the linear accelerator
was commissioned. 2000 MU was used as under calibration conditions, this would deliver
a maximum dose of 20 Gy to the film, the maximum dose to which the film is sensitive.
While due to the reduced field size (4x4 instead of 10x10, even before the collimation to
a 3 mm beam) it was highly unlikely that the dose would reach this level, I determined it
would be better to not risk overexposing the film.
The film was then scanned using a Epson v700 scanner and imported into FilmQA Pro
(Ashland Advanced Materials) for analysis. The calibration curve obtained for the the 192Ir
measurements was again used to convert from optical density to dose.
4.4 Results
4.4.1 2 MV simulations
Tables 4.1 and 4.2 show the PVDRs and dose rates, respectively, for the 2 MV system for
different center-to-center spacings. As with the isotope systems, the PVDR increases with
increased center-to-center spacing while the dose rate remains relatively unaffected. The
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Figure 4.2: Set up for the 6 MV irradiation. The MV imager was used as a secondary check
to verify the alignment between the two halves of the collimator. The solid water was set
to be at 100 SSD.
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dose rate for each beam is significantly higher for the 2 MV beam compared to the isotope
based cases, with a dose rate at depth of approximately 7 Gy/min. However, based on the
proposed design of the system where an electron beam is scanned across each collimator
hole, each of which holds a target, this is truly the dose rate in a single beam, so the effective
dose rate (the dose rate averaged over the full treatment time) would approximately be the
values in the table divided by the number of beams used for treatment. These dose rates
include the contribution from cross-talk from adjacent beams, so the dose rate would be
slightly lower for holes on the edge.
Table 4.1: PVDR results obtained with MCNP6 for different center-to-center spacings from
the 2 MV beam
Depth in phantom (cm)
PVDR
4 mm c-t-c 6 mm c-t-c 8 mm c-t-c 10 mm c-t-c 12 mm c-t-c
0.5 22.7 59.3 94.2 130.5 165.9
2.5 7.1 31.9 56.8 77.0 101.3
5.0 1.3 13.4 31.6 49.3 60.7
7.5 0.7 4.6 17.8 29.9 43.7
10.0 0.6 1.5 8.7 19.0 27.4
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Table 4.2: Beam centerline Dose rate per beam using maximum current (0.4 mA) for dif-
ferent center-to-center spacings from the 2 MV simulations
Depth in phantom (cm)
Dose rate (Gy/min)
4 mm c-t-c 6 mm c-t-c 8 mm c-t-c 10 mm c-t-c 12 mm c-t-c
0.5 77.3 76.6 76.3 76.1 76.1
2.5 42.7 42.1 41.9 41.7 41.7
5.0 22.9 22.2 22.0 21.9 21.8
7.5 13.5 12.7 12.5 12.4 12.4
10.0 8.9 7.7 7.5 7.4 7.4
As an example, assuming a prescription dose of 15 Gy to 10 cm and using the 8 mm
c-t-c spacing, this leads to a treatment time of 2 minutes per beam. If we limit treatment
time to 30 minutes, not including set up time, this means that the largest number of beams
that could be used is 15. Using Equation 4.1, which gives the number of holes, N , needed
to treat an area with radius r using a hexagonal array with a center-to-center spacing of ctc,
this would treat an area with a radius somewhere between 1-2 c-t-c distances, or between 8
and 16 mm.









And while the dose in-beam at the surface would receive a high dose of 152.6 Gy, the
valley region would only receive 1.6 Gy due to the high PVDR.
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4.4.2 6 MV film measurements
While FilmQA Pro does not output a 2D dose map, Figure 4.3 shows the film itself after
irradiation. The film was irradiated with a 4x4 field, the extend of the field can be seen
around the main beam as a slight darkening, caused by leakage through the collimator.
Compared to the 192Ir film, the beam remains well defined throughout the entire length of
the film.
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Figure 4.3: 6 MV film, post irradiation
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For the 6 MV films, the PVDRs were calculated by dividing the dose at center-line by
the dose measured at a distance equal to half of the center-to-center distance off axis. For
all of these measurements, the dose was averaged over 10 pixels to reduce the influence of
noise on the results. Based on the film resolution, this averaged over a distance of 0.3 mm,
which is small relative to the beam size. The PVDR results can be seen in Table 4.3. The
PVDR results were based on superpositions of the single hole results obtained from film
measurement.
Table 4.3: PVDR results obtained from film measurement for different center-to-center
spacings from 6 MV film irradiation
Depth in phantom (cm)
PVDR
6 mm c-t-c 8 mm c-t-c 10 mm c-t-c 12 mm c-t-c
0.5 6.0 8.1 9.7 10.7
2.5 4.9 6.6 8.2 9.5
5.0 5.1 7.3 9.3 11.0
7.5 5.5 7.7 9.9 11.8
10.0 5.2 7.3 9.4 11.3
12.5 4.7 6.7 8.8 10.6
15.0 4.1 5.8 7.5 9.0
17.5 3.8 5.3 6.9 8.5
20.0 3.2 4.5 5.9 7.4
As the films were irradiated to 2000 MU using a dose rate of 600 MU/min, the doses
measured from the film were divided by
2000MU
600MU/min
= 3.33min to give the dose rate
in Gy/min. The dose rate at various depths can be seen in Table 4.4.
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Table 4.4: Beam centerline dose rate (using 600 MU/min)











4.5.1 2 MV beams
From a PVDR standpoint, the 2 MV beams performed quite well, with similar PVDRs to
the 60Co at the surface. As with the 60Co, the PVDR stayed fairly high throughout the
volume of interest which, while not necessarily an issue, would not give a close to uniform
dose to a tumor volume. As current MV GRID treatments give beneficial clinical results
with lower PVDRs and similarly non-uniform dose to the tumor volume while using larger
beam sizes, it is likely that the dose distribution resulting from the 2 MV beams would re-
sult in at worst comparable clinical results and at best similar tumor control with increased
healthy tissue recovery. As with the photon-emitting radioisotope cases, the divergence
of the beam causes the dose profile to be close to uniform at certain depths for particular
center-to-center distances, which could be used to deny a tumor at these depths any advan-
tage from the spatial fractionation of the dose. As touched on in the results section, the dose
rate, while it appears to be sufficiently high from Table 4.2, is of somewhat more concern.
This stems from that the given dose rate is per beam, not for the overall system, meaning
that the time needed to deliver the prescription dose using the given dose rates would need
to be multiplied by the number of beams, as the electron beam would need to be scanned
across each of the targets in series. While this is doable for small field sizes, as mentioned
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earlier the number of holes increases by the function given by Equation 4.1.
This means that the treatment time will increase proportionally with this function, again
leading to drastically increased treatment times for larger fields. As with the isotopes, this
restriction on the dose rate limits the applicability of the system, but at least the MV system
has the potential of having short treatment times for small fields and does not require the
use of multiple kiloCuries of radioactive sources.
4.5.2 6 MV beam
While not a significant improvement from current MV GRID, the PVDRs obtained from the
6 MV treatment were up to two times higher than the current practice. Of course, this does
come with some caveats. The ratio of center-to-center spacing to beam diameter (which
is proportional to the closed to open ratio of the collimator) is higher in almost all cases
investigated in the work (2-4 for 6 to 12 mm c-t-c) than for the GRID collimators produced
today, which have a ctc:diameter ratio of 2. For the 6 mm c-t-c beams, the minibeam PVDR
is approximately equal to the standard GRID block. Additionally, the collimator used in
this study has a density thickness of approximately 112.2 g/cm2 (18.7 g/cm3 × 6 cm) and
a Z of 74, while the standard brass GRID block produced by .decimal (Sanford, FL) has
an approximate density thickness of 65.2 g/cm2 (8.55 g/cm3 × 7.62 cm) and a Zeff of
approximately 30. Based on this, one would expect the tungsten collimator to give a higher
PVDR than the brass.
The dose rate, as is the norm for this work, is concerning. While standard MV GRID
collimator has a output factor of approximately 0.89 (that is, the dose to Dmax for a given
number of MU is 89% of what it would be with an open field). Comparatively, the output
factor for the 3 mm beam size is 0.38 (using the reduced Dmax depth of 0.8 cm for the
3 mm beam), a comparative 57% decrease in output. This would lead to treatment times
that were approximately twice as long, which would mean there would be a greater risk
of patient motion that would blur the minibeams. However, this treatment time would still
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be shorter than GRID treatments administered using the MLC, which are on average 5
times longer than treatments administered with a static block [18, 23]. Given this, it is
potentially feasible to use a GRID block with 3 mm holes from a dosimetric prospective,
though practically it would be challenging for the reasons mentioned below.
4.6 Conclusions
Both of the MV minibeam techniques evaluated do show some promise for clinical ap-
plication. In both cases, the PVDRs at the surface were at or above the values found for
clinically used MV GRID treatments, which implies that the normal tissue recovery would
at worst be the same as these treatments. As shown in Hopewell et. al. [2], we have reason
to believe that the smaller beam size of 2-3 mm would lead to a radiobiological advantage.
The dose rate, while not as high as hoped, is still high enough in most cases (excluding
large fields for the 2 MV beams) to be clinically viable, as the treatment times would be
less than for those MLC administered GRID treatments [18, 23, 16]. However, the tech-
nical implementation for both would be challenging. The 2 MV beams would require the
development of a 2 MeV electron accelerator that would also need to be capable of steering
the beam onto the targets located at the top of each collimator hole. Each of these targets
would also need to be cooled to assure that the incident electron beam did not melt either
the target or the attached filter. Furthermore, due to the small beam size, performing cal-
ibration measurements for such a system would be difficult, and would almost certainly
require the use of radiochromic film. While the makers of the EBT3 film used in this work
assure measured dose accuracy within 1% [47], the practice standards set by the American
Association of Physicists in Medicine (AAPM) specify that only an ion chamber in water
should be used for calibrating clinical linear accelerators [58]. Another concern for both
would be machining the tungsten collimators. The collimators would likely have to be ma-
chined in at least two separate parts, as even the 3 cm tungsten pieces stretched the limits of
the machine shop, requiring tens of minutes for each piece and two drill bits as one broke
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during the process. To cover a treatment area of 10x10 cm would require a minimum of 64
holes (using a c-t-c of 12 mm) all the way up to 625 holes (for 4 mm c-t-c) or 256 holes (for
6 mm c-t-c). In the case of the 6 MV collimator, these holes would have to be divergent
to match the beam coming from the linear accelerator (to avoid the ”doming” effect shown
for the smaller electron hole sizes in chapter 2), adding another degree of complexity. One
way around this problem could be to switch the collimator material to something that would
be easier to machine, such as brass or Cerrobend. The tradeoff would be either increased
leakage (due to a decrease in both the Zeff and the density thickness) if the thickness was
kept the same, or decreased output if the collimator thickness was increased due to the 1/r2
effect (for the 2 MV case, as the targets would be moved further from the surface) and re-
duce solid angle (for both). Should future research look into developing these systems for
applied clinical use, identifying a new collimator material and design that would minimize
the drawbacks of not using tungsten should be a high priority.
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CHAPTER 5
CONCLUSIONS AND FUTURE WORK
5.1 Conclusions
Overall, the methodologies explored in this work showed some promise, though in each
case this was tempered by several limitations. For the electron GRID, the PVDRs obtained
were on the order of those achieved in commercial MV GRID treatment systems, and the
lateral scattering of the electrons did lead to a more uniform dose below the skin surface.
However, while the electrons did meet the goal of minimizing exit dose, and therefore the-
oretically sparing any radiosensative structures below the treatment volume, the effective
treatment depth was also reduced to a point that would make treating the entire volume of
a bulky tumor difficult at best and impossible at worst. Still, there are theoretically some
cases where this could be applied, though the restrictions on what would make an ideal
case (a tumor that is bulky in two dimensions but is relatively thin in the depth dimension
and is located above an organ-at-risk) are more limiting than was initially hoped.
For the radioisotope-based photon minibeams, it was indeed possible to create 2-3 mm
diameter beams with relatively high PVDRs using both 192Ir and 60Co. Unfortunately, the
dose rate obtained with the majority of the configurations investigated was relatively low,
around 0.4-0.6 Gy/min, and the treatment of even a small area would require kiloCuries
worth of the isotopes. The convergent 60Co geometry showed the most promise of all of
the cases, with a respectable dose rate of approximately 3 Gy/min in the target volume,
and the use of less activity than a GammaKnife unit (abet spread across significantly fewer
sources).
Finally, the MV minibeams followed a similar pattern as the isotopes, achieving excel-
lent PVDRs but hampered by low effective dose rates. The 2 MV minibeams additionally
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added in a large degree of technical complexity, as a 2 MeV electron accelerator would not
only have to be produced, but would need to have a steering system accurate enough to
quickly scan between an array of 2 mm targets. The 6 MV measurement did show some
promise, though again hampered by a low dose rate relative to the typical dose prescription
for GRID treatments. Still, as a modification of an existing clinical treatment, it also would
almost certainly be the easiest to bring into use for patient treatments.
5.2 Future work
As noted above, the two most promising areas for future work would be the convergent
60Co isotope treatment and the 6 MV GRID collimator. In the case of the 60Co system,
likely future directions would be to evaluate the feasibility of obtaining and handling the
activity of sources needed to make the system work and/or look into expanding the number
of beam lines to both lower the dose per beam and lower the activity per source. Ideally,
the largest number of beam lines that still would allow for the system to be able to change
position around the patient would be used, as the more beam lines the less difficult there
would be in handling any individual source, but using so many as to make the machine
fixed would render it effectively identical to existing GammaKnife units.
For the MV minibeams, the main challenge would be to find a way to machine a prop-
erly divergent collimator. As mentioned in Chapter 4, even machining a single straight
hole through half of the effective thickness of the tungsten collimator took a considerable
amount of time and effort. As such, it is likely a different, more easily machined colli-
mator material would be used instead (with hopefully minimal trade off in the PVDR and
dose rate). The other issue would be to find the ideal trade-off in positioning of the col-
limator, as if it is brought closer to the head of the machine, the hole size would need to
be decreased to assure the projection on the patient’s skin does not exceed 5 mm while
positioning it closer to the patient would require a more complex mounting apparatus and






A.1 Electron film analysis code
function [out,len,wid]=Film2Dose(fname,channel,energy)
calMUs=600; %MUs used to generate the films













MU2Gy=.01009; %MU to gray conversion from TEC3


























































































title(’Percent of max dose’);
figure;
















function [fitresult, gof] = createFit(x, y)
%CREATEFIT(X,Y)
% Create a fit.
%
% Data for ’untitled fit 1’ fit:
% X Input : x
% Y Output: y
% Output:
% fitresult : a fit object representing the fit.
% gof : structure with goodness-of fit info.
%
% See also FIT, CFIT, SFIT.
% Auto-generated by MATLAB on 02-Jun-2016 15:44:44
%% Fit: ’untitled fit 1’.
[xData, yData] = prepareCurveData( x, y );
% Set up fittype and options.
% opts = fitoptions( ’Method’, ’NonlinearLeastSquares’ );
% opts.Display = ’Off’;
% opts.StartPoint = ;
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ft = fittype( ’a+b/(x-c)’, ’independent’, ’x’, ’dependent’, ’y’ );
% Fit model to data.
[fitresult, gof] = fit( xData, yData, ft, ’StartPoint’,
[0.54630955549147 0.0211108546124322 0]);
% Plot fit with data.
figure( ’Name’, ’Calibration Curve’ );
h = plot( fitresult, xData, yData );





















if exist([pwd ’/’ num2str(standOff*10) ’mmST’],’dir’)˜=7
mkdir([pwd ’/’ num2str(standOff*10) ’mmST’])
end






if strcmpi(shape(1),’t’) || strcmpi(shape(1),’s’)
type=’T’;




fprintf(fid,[’Center beam,’ num2str(ceil(coll)) ’mm Tube Collimator,
’ num2str(c2c) ’mm C2C spacing P\n’...
fprintf(fid,’c Cell Card\n’);
fprintf(fid,’1 1 -0.001225 -1 2 3 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’2 2 -1 -2 IMP:p=10 IMP:e=10\n’);
fprintf(fid,[’3 3 -’ num2str(collDen) ’ -3 5 6 IMP:p=0 IMP:e=0\n’]);
fprintf(fid,’4 1 -0.001225 -4 5 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’5 4 -22.56 -5 IMP:p=1 IMP:e=0\n’);
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fprintf(fid,’6 0 1 IMP:p=0 IMP:e=0\n’);
fprintf(fid,[’7 3 -’ num2str(collDen) ’ -6 4 5 IMP:p=1 IMP:e=0\n’]);
fprintf(fid,’\n’);
fprintf(fid,’c Surface Card\n’);
fprintf(fid,[’1 RPP -10 10 -10 10 -10 ’ num2str(10+standOff+2*collThickness+3)
’ $ air\n’]);
fprintf(fid,’2 RPP -5 5 -5 5 -5 10 $ water\n’);
fprintf(fid,[’3 RPP -2.5 2.5 -2.5 2.5 ’ num2str(10+standOff) ’
’ num2str(10+standOff+2*collThickness) ’ $ collimator\n’]);
fprintf(fid,[’4 RCC 0 0 ’ num2str(10+standOff) ’ 0 0 ’ num2str(collThickness+.15) ’
’ num2str(coll/20) ’ $ hole\n’]);
fprintf(fid,[’5 RCC 0 0 ’ num2str(10+collThickness-.1+standOff) ’ 0 0 .2 ’
num2str(sourceS/20) ’ $ source\n’]);
fprintf(fid,[’6 RCC 0 0 ’ num2str(10+standOff) ’ 0 0 ’ num2str(collThickness+.15) ’
’ num2str(coll/20+.2) ’ $ important area around hole\n’]);
fprintf(fid,’\n’);
fprintf(fid,’Mode p e\n’);
fprintf(fid,[’SDEF ERG=d1 POS=0 0 ’ num2str(10+collThickness-.1+standOff) ’
AXS=0 0 1 EXT=D4 RAD=D5 PAR=2 VEC=0 0 -1 DIR=D6\n’]);




fprintf(fid,[’SI5 0 ’ num2str(coll/20) ’\n’]);
fprintf(fid,’SP5 -21 1 \n’);
ang=atan((coll/2)/(collThickness*10/2))+.1;
fprintf(fid,[’SI6 -1 ’ num2str(cos(ang)) ’ 1\n’]);
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fprintf(fid,[’SP6 0 ’ num2str((2-(1-cos(ang)))/2) ’ ’ num2str((1-cos(ang))/2) ’\n’]);
fprintf(fid,’SB6 0 0 1\n’);
fprintf(fid,’TMESH\n’);
fprintf(fid,’ RMESH13 \n’);
fprintf(fid,[’ CORA13 -’ num2str(c2c/10+1) ’ ’ num2str(((c2c/10)+1)*2/res-1) ’i ’
num2str(c2c/10+1) ’\n’]);
fprintf(fid,[’ CORB13 -’ num2str(res/2) ’ ’ num2str(res/2) ’\n’]);
fprintf(fid,[’ CORC13 -5 ’ num2str((15/res)-1) ’i 10\n’]);
fprintf(fid,’ ENDMD\n’);
fprintf(fid,’M1 008016 -.231781 006012 -.000124 007014 -.755268 018040 -.012827 GAS=1\n’);
fprintf(fid,’M2 008016 1 001000 2\n’);
%fprintf(fid,’M3 072000 1\n’); % tungsten









fprintf(fid,[’Diag beam,’ num2str(ceil(coll)) ’mm Tube Collimator, ’
num2str(c2c) ’mm C2C spacing P\n’]);
fprintf(fid,’c Cell Card\n’);
fprintf(fid,’1 1 -0.001225 -1 2 3 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’2 2 -1 -2 IMP:p=10 IMP:e=10\n’);
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fprintf(fid,[’3 3 -’ num2str(collDen) ’ -3 5 6 IMP:p=0 IMP:e=0\n’]);
fprintf(fid,’4 1 -0.001225 -4 5 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’5 4 -22.56 -5 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’6 0 1 IMP:p=0 IMP:e=0\n’);
fprintf(fid,[’7 3 -’ num2str(collDen) ’ -6 5 4 IMP:p=1 IMP:e=0\n’]);
fprintf(fid,’\n’);
fprintf(fid,’c Surface Card\n’);
fprintf(fid,[’1 RPP -10 10 -10 10 -10 ’ num2str(10+standOff+2*collThickness+3) ’ $ air\n’]);
fprintf(fid,’2 RPP -5 5 -5 5 -5 10 $ water\n’);
fprintf(fid,[’3 RPP ’ num2str(newLoc-2.5) ’ ’ num2str(newLoc+2.5) ’ ’ num2str(newLoc-2.5) ’ ’
num2str(newLoc+2.5) ’ ’ num2str(standOff+10) ’ ’ num2str(10+standOff+collThickness*2) ’ $ collimator\n’]);
fprintf(fid,[’4 RCC ’ num2str(newLoc) ’ ’ num2str(newLoc) ’ ’ num2str(standOff+10) ’ 0 0 ’
num2str(collThickness+.15) ’ ’ num2str(coll/20) ’ $ hole\n’]);
fprintf(fid,[’5 RCC ’ num2str(newLoc) ’ ’ num2str(newLoc) ’ ’ num2str(10+collThickness-.1+standOff)
’ 0 0 .2 ’ num2str(sourceS/20) ’ $ source\n’]);
fprintf(fid,[’6 RCC ’ num2str(newLoc) ’ ’ num2str(newLoc) ’ ’ num2str(standOff+10) ’ 0 0
’ num2str(collThickness+.15) ’ ’ num2str(coll/20+.2) ’ $ important area around hole\n’]);
fprintf(fid,’\n’);
fprintf(fid,’Mode p e\n’);
fprintf(fid,[’SDEF ERG=d1 POS=’ num2str(newLoc) ’ ’ num2str(newLoc) ’ ’ num2str(10+collThickness-.1+standOff)
’\n AXS=0 0 1 EXT=D4 RAD=D5 PAR=2 VEC=0 0 -1 DIR=D6\n’]);




fprintf(fid,[’SI5 0 ’ num2str(coll/20) ’\n’]);
fprintf(fid,’SP5 -21 1 \n’);
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ang=atan((coll/2)/(collThickness*10/2))+.1;
fprintf(fid,[’SI6 -1 ’ num2str(cos(ang)) ’ 1\n’]);
fprintf(fid,[’SP6 0 ’ num2str((2-(1-cos(ang)))/2) ’ ’ num2str((1-cos(ang))/2) ’\n’]);
fprintf(fid,’SB6 0 0 1\n’);
fprintf(fid,’TMESH\n’);
fprintf(fid,’ RMESH13 \n’);
fprintf(fid,[’ CORA13 -’ num2str(c2c/10+1) ’ ’ num2str(((c2c/10)+1)*2/res-1) ’i ’ num2str(c2c/10+1) ’\n’]);
fprintf(fid,[’ CORB13 -’ num2str(res/2) ’ ’ num2str(res/2) ’\n’]);
fprintf(fid,[’ CORC13 -5 ’ num2str((15/res)-1) ’i 10\n’]);
fprintf(fid,’ ENDMD\n’);
fprintf(fid,’M1 008016 -.231781 006012 -.000124 007014 -.755268 018040 -.012827 GAS=1\n’);
fprintf(fid,’M2 008016 1 001000 2\n’);
%fprintf(fid,’M3 072000 1\n’); %tungsten









fprintf(fid,[’Center beam,’ num2str(ceil(coll)) ’mm Funnel Collimator, ’ num2str(c2c) ’mm C2C spacing\n’]);
fprintf(fid,’c Cell Card\n’);
fprintf(fid,’1 1 -0.001225 -1 2 3 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’2 2 -1 -2 IMP:p=10 IMP:e=10\n’);
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fprintf(fid,[’3 3 -’ num2str(collDen) ’ -3 6 IMP:p=0 IMP:e=0\n’]);
fprintf(fid,’4 1 -0.001225 -4 5 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’5 4 -22.56 -5 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’6 0 1 IMP:p=0 IMP:e=0\n’);
fprintf(fid,[’7 3 -’ num2str(collDen) ’ -6 4 5 IMP:p=1 IMP:e=0\n’]);
fprintf(fid,’\n’);
fprintf(fid,’c Surface Card\n’);
fprintf(fid,[’1 RPP -10 10 -10 10 -10 ’ num2str(10+standOff+2*collThickness+3) ’ $ air\n’]);
fprintf(fid,’2 RPP -5 5 -5 5 -5 10 $ water\n’);
fprintf(fid,[’3 RPP -2.5 2.5 -2.5 2.5 ’ num2str(standOff+10) ’ ’
num2str(10+standOff+collThickness*2) ’ $ collimator\n’]);
fprintf(fid,[’4 TRC 0 0 ’ num2str(standOff+10) ’ 0 0 ’ num2str(collThickness+.15) ’ ’
num2str(coll/20) ’ ’ num2str(sourceS/20) ’ $ hole\n’]);
fprintf(fid,[’5 RCC 0 0 ’ num2str(10+collThickness-.1+standOff) ’ 0 0 .2 ’ num2str(sourceS/20) ’
$ source\n’]);
fprintf(fid,[’6 TRC 0 0 ’ num2str(standOff+10) ’ 0 0 ’ num2str(collThickness+.15) ’ ’
num2str(coll/20+.2) ’ ’ num2str(sourceS/20+.2) ’ $ important area around hole\n’]);
fprintf(fid,’\n’);
fprintf(fid,’Mode p e\n’);
fprintf(fid,[’SDEF ERG=d1 POS=0 0 ’ num2str(10+collThickness-.1+standOff) ’
AXS=0 0 1 EXT=D4 RAD=D5 PAR=2 VEC=0 0 -1 DIR=D6\n’]);




fprintf(fid,[’SI5 0 ’ num2str(sourceS/20) ’\n’]);
fprintf(fid,’SP5 -21 1 \n’);
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ang=atan((coll/2)/(collThickness*10/2))+.1;
fprintf(fid,[’SI6 -1 ’ num2str(cos(ang)) ’ 1\n’]);
fprintf(fid,[’SP6 0 ’ num2str((2-(1-cos(ang)))/2) ’ ’ num2str((1-cos(ang))/2) ’\n’]);
fprintf(fid,’SB6 0 0 1\n’);
fprintf(fid,’TMESH\n’);
fprintf(fid,’ RMESH13 \n’);
fprintf(fid,[’ CORA13 -’ num2str(c2c/10+1) ’ ’ num2str(((c2c/10)+1)*2/res-1) ’i ’ num2str(c2c/10+1) ’\n’]);
fprintf(fid,[’ CORB13 -’ num2str(res/2) ’ ’ num2str(res/2) ’\n’]);
fprintf(fid,[’ CORC13 -5 ’ num2str((15/res)-1) ’i 10\n’]);
fprintf(fid,’ ENDMD\n’);
fprintf(fid,’M1 008016 -.231781 006012 -.000124 007014 -.755268 018040 -.012827 GAS=1\n’);
fprintf(fid,’M2 008016 1 001000 2\n’);
%fprintf(fid,’M3 072000 1\n’); %tungsten








fprintf(fid,[’Center beam,’ num2str(ceil(coll)) ’mm Funnel Collimator, ’ num2str(c2c) ’mm C2C spacing\n’]);
fprintf(fid,’c Cell Card\n’);
fprintf(fid,’1 1 -0.001225 -1 2 3 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’2 2 -1 -2 IMP:p=10 IMP:e=10\n’);
fprintf(fid,[’3 3 -’ num2str(collDen) ’ -3 6 IMP:p=0 IMP:e=0\n’]);
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fprintf(fid,’4 1 -0.001225 -4 5 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’5 4 -22.56 -5 IMP:p=1 IMP:e=0\n’);
fprintf(fid,’6 0 1 IMP:p=0 IMP:e=0\n’);
fprintf(fid,[’7 3 -’ num2str(collDen) ’ -6 4 5 IMP:p=1 IMP:e=0\n’]);
fprintf(fid,’\n’);
fprintf(fid,’c Surface Card\n’);
fprintf(fid,[’1 RPP -10 10 -10 10 -10 ’ num2str(10+standOff+2*collThickness+3) ’ $ air\n’]);
fprintf(fid,’2 RPP -5 5 -5 5 -5 10 $ water\n’);
fprintf(fid,[’3 RPP ’ num2str(newLoc-2.5) ’ ’ num2str(newLoc+2.5) ’ ’ num2str(newLoc-2.5) ’ ’
num2str(newLoc+2.5) ’ ’ num2str(standOff+10) ’ ’ num2str(10+standOff+collThickness*2) ’ $ collimator\n’]);
fprintf(fid,[’4 TRC ’ num2str(newLoc) ’ ’ num2str(newLoc) ’ ’ num2str(standOff+10) ’ 0 0 ’
num2str(collThickness+.15) ’ ’ num2str(coll/20) ’ ’ num2str(sourceS/20) ’ $ hole\n’]);
fprintf(fid,[’5 RCC ’ num2str(newLoc) ’ ’ num2str(newLoc) ’ ’ num2str(10+collThickness-.1+standOff)
’ 0 0 .2 ’ num2str(sourceS/20) ’ $ source\n’]);
fprintf(fid,[’6 TRC ’ num2str(newLoc) ’ ’ num2str(newLoc) ’ ’ num2str(standOff+10) ’ 0 0 ’
num2str(collThickness+.15) ’ ’ num2str(coll/20+.2) ’ ’ num2str(sourceS/20+.2) ’ $ important area around hole\n’]);
fprintf(fid,’\n’);
fprintf(fid,’Mode p e\n’);
fprintf(fid,[’SDEF ERG=d1 POS=’ num2str(newLoc) ’ ’ num2str(newLoc) ’ ’ num2str(10+collThickness-.1+standOff)
’\n AXS=0 0 1 EXT=D4 RAD=D5 PAR=2 VEC=0 0 -1 DIR=D6\n’]);




fprintf(fid,[’SI5 0 ’ num2str(sourceS/20) ’\n’]);
fprintf(fid,’SP5 -21 1 \n’);
ang=atan((coll/2)/(collThickness*10/2))+.1;
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fprintf(fid,[’SI6 -1 ’ num2str(cos(ang)) ’ 1\n’]);
fprintf(fid,[’SP6 0 ’ num2str((2-(1-cos(ang)))/2) ’ ’ num2str((1-cos(ang))/2) ’\n’]);
fprintf(fid,’SB6 0 0 1\n’);
fprintf(fid,’TMESH\n’);
fprintf(fid,’ RMESH13 \n’);
fprintf(fid,[’ CORA13 -’ num2str(c2c/10+1) ’ ’ num2str(((c2c/10)+1)*2/res-1) ’i ’ num2str(c2c/10+1) ’\n’]);
fprintf(fid,[’ CORB13 -’ num2str(res/2) ’ ’ num2str(res/2) ’\n’]);
fprintf(fid,[’ CORC13 -5 ’ num2str((15/res)-1) ’i 10\n’]);
fprintf(fid,’ ENDMD\n’);
fprintf(fid,’M1 008016 -.231781 006012 -.000124 007014 -.755268 018040 -.012827 GAS=1\n’);
fprintf(fid,’M2 008016 1 001000 2\n’);
%fprintf(fid,’M3 072000 1\n’); %tungsten





system([’mcnp6 i=’ fname1 ’ mdata=’ mdata1]);








































































































% sampleFrequency=1; %in cm
% samples=0:sampleFrequency:12;
% samples(1)=[];
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